WALL STREET ASSOCIATES - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 52 filers reported holding NEOS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WALL STREET ASSOCIATES ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$983,000
-29.1%
149,3430.0%0.34%
-39.5%
Q2 2016$1,386,000
-14.0%
149,3430.0%0.55%
-17.2%
Q1 2016$1,611,000
-24.7%
149,3430.0%0.67%
+11.1%
Q4 2015$2,139,000
-48.9%
149,343
-25.1%
0.60%
-24.8%
Q3 2015$4,188,000199,3430.80%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
DSC Advisors, L.P. 693,582$4,057,0002.30%
DAFNA Capital Management LLC 38,873$227,0000.20%
FALCON POINT CAPITAL, LLC 85,588$501,0000.07%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 229,166$1,341,0000.06%
Cormorant Asset Management, LP 50,613$296,0000.04%
PRELUDE CAPITAL MANAGEMENT, LLC 14,587$85,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 80,000$468,0000.01%
MILLENNIUM MANAGEMENT LLC 296,175$1,733,0000.00%
FRANKLIN RESOURCES INC 1,315,500$7,696,0000.00%
COLUMBUS CIRCLE INVESTORS 42,304$247,0000.00%
View complete list of NEOS THERAPEUTICS INC shareholders